Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Amyotrophic lateral sclerosis

Abstract

Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system. In this Seminar, we summarise current concepts about the origin of the disease, what predisposes patients to develop the disorder, and discuss why all cases of ALS are not the same. In the 150 years since Charcot originally described ALS, painfully slow progress has been made towards answering these questions. We focus on what is known about ALS and where research is heading-from the small steps of extending longevity, improving therapies, undertaking clinical trials, and compiling population registries to the overarching goals of establishing the measures that guard against onset and finding the triggers for this neurodegenerative disorder.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)61156-7

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 142 references

Research works printed but not linked: 4

  1. Gordon, 2006, The natural history of primary lateral sclerosis, Neurology, 66, 647, 10.1212/01.wnl.0000200962.94777.71 · DOI · Paper page
  2. Kiernan, 2003, Motor neuron disease: a Pandora's box, MJA, 178, 311
  3. Turner, 2005, Distinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [11C]flumazenil PET, Brain, 128, 1323, 10.1093/brain/awh509 · DOI · Paper page
  4. Desport, 2005, Hypermetabolism in ALS: correlations with clinical and paraclinical parameters, Neurodegener Dis, 2, 202, 10.1159/000089626 · DOI · Paper page

Cited by

See all 2,603

Metadata

Authors
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C.
Affiliations
  • UNSW Sydney (AU)
  • The University of Sydney (AU)
  • University of Oxford (GB)
  • University of British Columbia (CA)
  • Trinity College Dublin (IE)
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-03
Volume
377
Issue
9769
Pages
942-955
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2913609543
Cited by
2,603
References
142
Citations by year
2026: 115 · 2025: 166 · 2024: 181 · 2023: 200 · 2022: 210 · 2021: 240 · 2020: 209 · 2019: 172 · 2018: 197 · 2017: 212 · 2016: 187 · 2015: 158 · 2014: 115 · 2013: 109 · 2012: 92
FWCI
13.93
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, motor neuron disease, neurodegeneration, pathogenesis, genetic susceptibility, disease heterogeneity, ALS risk factors, ALS therapy, clinical trials, population registers
MeSH terms
Amyotrophic Lateral Sclerosis, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1016/s0140-6736(10)61156-7
The paper
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011). Amyotrophic lateral sclerosis. The Lancet. https://doi.org/10.1016/s0140-6736(10)61156-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.